Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Order: Signal: Tickers:
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Quotes Basic TA News Snapshot
Total: 170 #1
TickerABC [NYSE, S&P 500]
CompanyAmerisourceBergen Corporation
IndustryDrugs Wholesale
Market Cap17.89BEPS (ttm)1.12
P/E71.20EPS this Y-29.10%
Forward P/E18.21EPS next Y11.97%
PEG4.76EPS past 5Y7.80%
P/S0.16EPS next 5Y14.97%
P/B9.06EPS Q/Q-122.20%
Dividend1.18%Sales Q/Q38.50%
Insider Own0.20%Inst Own85.90%
Insider Trans0.22%Inst Trans-0.49%
Short Float2.97%EarningsOct 30/b
Analyst Recom2.10Target Price81.09
Avg Volume1.49M52W Range62.14 - 80.19
30-Oct-14 01:25PMStocks Improve In Afternoon Trading; Taser Surges On Earnings at Investor's Business Daily
30-Oct-14 12:45PMAmerisourceBergen Shows More Accelerating EPS Growth at Investor's Business Daily
30-Oct-14 11:15AMAmerisourceBergen Beats on Q4 Earnings, Guides Well Zacks
30-Oct-14 11:00AMAmerisourceBergen Corp Earnings Call scheduled for 11:00 am ET today CCBN
30-Oct-14 10:23AMAMERISOURCEBERGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, F EDGAR Online
30-Oct-14 09:48AMWatch For Today's Momo Momentum Stock: AmerisourceBergen (ABC) at TheStreet
30-Oct-14 07:37AMAmerisourceBergen beats Street 4Q forecasts AP
30-Oct-14 07:33AM[$$] AmerisourceBergen Profit, Revenue Increase at The Wall Street Journal
30-Oct-14 07:21AM7:21 am AmerisourceBergen beats by $0.05, beats on revs; guides FY15 EPS in-line, FY15 above consensus Briefing.com
30-Oct-14 07:07AMQ4 2014 AmerisourceBergen Corp Earnings Release - Before Market Open CCBN
AmerisourceBergen Corporation sources and distributes pharmaceutical products to healthcare providers, pharmaceutical and biotech manufacturers, and specialty drug patients in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; scalable automated pharmacy dispensing equipment; medication and supply dispensing cabinets; and packaging solutions to institutional and retail healthcare providers. In addition, this segment provides pharmaceutical distribution and other services primarily to physician practices in various disease states, such as oncology, as well as to other healthcare providers, including dialysis clinics; distributes plasma and other blood products, injectible pharmaceuticals, and vaccines; and third party logistics and outcomes research, and other services for biotechnology and other pharmaceutical manufacturers. The company's Other segment provides commercialization support services, including reimbursement support programs, outcomes research, contract field staffing, patient assistance and copay assistance programs, adherence programs, risk mitigation services, and other market access programs to pharmaceutical and biotechnology manufacturers; and specialty transportation and logistics services for the biopharmaceutical industry. AmerisourceBergen Corporation markets its products and services through independent sales forces and marketing organizations. The company was founded in 1985 and is based in Chesterbrook, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GOZON RICHARD CDirectorSep 15Option Exercise15.3218,520283,76261,604Sep 16 04:05 PM
GOZON RICHARD CDirectorSep 15Sale776.6318,52014,383,10243,084Sep 16 04:05 PM
HAGENLOCKER EDWARD EDirectorSep 08Sale78.094,852378,8700Sep 09 08:26 PM
Guttman Tim G.Chief Financial OfficerMay 27Option Exercise21.466,375136,80830,649May 28 08:31 PM
Chou John G.Executive Vice PresidentMay 22Option Exercise21.4637,500804,75068,149May 23 07:53 AM
CompanyABIOMED, Inc.
IndustryMedical Appliances & Equipment
Market Cap1.03BEPS (ttm)0.17
P/E149.12EPS this Y-51.40%
Forward P/E52.92EPS next Y295.87%
PEG6.94EPS past 5Y17.10%
P/S5.40EPS next 5Y21.50%
P/B5.96EPS Q/Q0.00%
Dividend-Sales Q/Q14.30%
Insider Own2.60%Inst Own-
Insider Trans7.57%Inst Trans-0.01%
Short Float17.68%EarningsOct 30/b
Analyst Recom2.00Target Price28.38
Avg Volume218.93K52W Range20.29 - 30.77
30-Oct-14 01:17PMNasdaq stocks posting largest percentage increases AP
30-Oct-14 08:49AMABIOMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
30-Oct-14 08:28AMAbiomed tops Street 2Q forecasts AP
30-Oct-14 07:21AM7:21 am Abiomed misses by $0.04, beats on revs; raises lower end of FY15 guidance, above consensus Briefing.com
30-Oct-14 07:07AMQ2 2015 Abiomed Inc Earnings Release - Before Market Open CCBN
30-Oct-14 07:00AMAbiomed Announces Second Quarter Fiscal 2015 Revenue of $51.9 Million, Up 17% Over Prior Year GlobeNewswire
09-Oct-14 02:41PMAbiomed Second Quarter Fiscal 2015 Earnings and Conference Call Notification GlobeNewswire
18-Sep-14 04:02PMABIOMED Up on Positive Impella RP Clinical Trial Results Zacks
18-Sep-14 10:10AMAbiomed Appoints Ingrid Goldberg as Director of Investor Relations GlobeNewswire
16-Sep-14 05:03PMClinical Trial Results for Impella RP Right Ventricular Heart Failure Trial, RECOVER RIGHT, Released at TCT 2014 GlobeNewswire
ABIOMED, Inc. provides medical devices in circulatory support and continuum of care in heart recovery to acute heart failure patients. Its products consist of Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; Impella CP, a micro heart pump; and Impella 5.0 catheter and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite. The company also manufactures and sells the Impella RP, a percutaneous catheter-based axial flow pump; and AB5000 circulatory support system and the BVS 5000 biventricular support system for temporary support of acute heart failure patients in profound shock, including patients suffering from cardiogenic shock after a heart attack, post-cardiotomy cardiogenic shock, or myocarditis. In addition, it offers Symphony, a synchronized minimally invasive implantable cardiac assist device designed to treat chronic patients with moderate heart failure by improving patient hemodynamics; and AbioCor program. The company sells its products through direct sales and clinical support personnel in the United States, Canada, Germany, France, the United Kingdom, and internationally. ABIOMED, Inc. was founded in 1981 and is headquartered in Danvers, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Howley Michael GVP, Global Sales & MarketingApr 27Sale24.752,01649,89659,784Apr 30 03:08 PM
MINOGUE MICHAEL RPresident, CEO, ChairmanJul 28Option Exercise13.5725,411344,827243,622Jul 28 05:22 PM
MINOGUE MICHAEL RPresident, CEO, ChairmanJul 28Sale26.3025,411668,312218,211Jul 28 05:22 PM
MINOGUE MICHAEL RPresident, CEO, ChairmanJul 25Option Exercise13.5751,147694,065269,358Jul 28 05:22 PM
MINOGUE MICHAEL RPresident, CEO, ChairmanJul 25Sale26.3051,1471,345,171218,211Jul 28 05:22 PM
CompanyACI Worldwide, Inc.
IndustryTechnical & System Software
Market Cap2.20BEPS (ttm)0.56
P/E34.41EPS this Y29.30%
Forward P/E19.62EPS next Y27.53%
PEG1.72EPS past 5Y39.60%
P/S2.26EPS next 5Y20.00%
P/B13.11EPS Q/Q50.00%
Dividend-Sales Q/Q23.80%
Insider Own1.30%Inst Own98.80%
Insider Trans19.98%Inst Trans0.01%
Short Float5.32%EarningsOct 30/b
Analyst Recom2.60Target Price21.20
Avg Volume577.98K52W Range17.32 - 21.98
30-Oct-14 08:30AMACI Worldwide Inc Earnings Call scheduled for 8:30 am ET today CCBN
30-Oct-14 07:48AMACI WORLDWIDE, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib EDGAR Online
30-Oct-14 07:07AMQ3 2014 ACI Worldwide Inc Earnings Release - Before Market Open CCBN
30-Oct-14 06:21AMACI Worldwide tops 3Q profit forecasts AP
30-Oct-14 06:14AM6:14 am ACI Worldwide beats by $0.04, misses on revs Briefing.com
30-Oct-14 06:00AMACI Worldwide, Inc. Reports Financial Results for the Quarter Ended September 30, 2014 Business Wire
29-Oct-14 08:00AMACI Worldwide Named One of Americas Best Performing Companies by Forbes Business Wire
28-Oct-14 08:00AMACI Worldwide Presents Real-Time Payments Innovations at Money20/20 Business Wire
24-Oct-14 07:14AMCheck Point Software (CHKP) in Focus: Stock Rises 5.4% Zacks
23-Oct-14 08:30AMCitrix Systems Tops Q3 Earnings, Lags Revenues; Ups View Zacks
ACI Worldwide, Inc. develops, markets, installs, and supports software products and services for facilitating electronic payments worldwide. The company offers products and services covering various domains, including online banking and cash management that manages payments and cash flows through the online or mobile channel; managing and processing monetary, non monetary, sales, and account origination financial transactions; and managing trade related transaction types. The company's products also cover various domains within the payments and banking marketplace, such as community financial services, including online and mobile banking and payment systems, and security solutions; software to support in house issuance of payment instruments and management of a consumer payment from transaction acquiring to settlement; wholesale banking payments that manage corporate payments and messages through their lifecycle; and merchant retail, which manages a consumer payment within a merchant retailer and supporting services. In addition, its products cover payment fraud management, which secures payments against fraud and money laundering; and payment infrastructure to operate and optimize the payments system. Further, the company offers bill presentment and payment collection services to tax authorities, higher education, utilities, and health care providers, as well as provides implementation, product support, technical, educational, testing, expert consultancy, and facilities management services. ACI Worldwide, Inc. sells its products under the ACI Worldwide and ACI Payment Systems brands. It serves financial institutions, including national, regional, and global banks, as well as community banks and credit unions; e-payment processors; retailers; and billers. The company was formerly known as Transaction Systems Architects, Inc. and changed its name to ACI Worldwide, Inc. in July 2007. ACI Worldwide, Inc. was founded in 1993 and is headquartered in Naples, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HEASLEY PHILIP GCEO and PresidentOct 03Option Exercise7.55200,0001,510,0001,347,272Oct 07 05:09 PM
HEASLEY PHILIP GCEO and PresidentOct 03Sale19.11200,0003,822,0001,147,272Oct 07 05:09 PM
HEASLEY PHILIP GCEO and PresidentSep 11Option Exercise7.5519,979150,8411,167,251Sep 15 05:34 PM
HEASLEY PHILIP GCEO and PresidentSep 11Sale19.6119,979391,7881,147,272Sep 15 05:34 PM
CURTIS JOHN DDirectorAug 22Option Exercise7.5524,000181,20043,539Aug 26 04:59 PM
CompanyAcorda Therapeutics, Inc.
Market Cap1.50BEPS (ttm)0.45
P/E79.73EPS this Y-89.80%
Forward P/E113.90EPS next Y76.97%
PEG1.77EPS past 5Y16.80%
P/S4.22EPS next 5Y45.00%
P/B2.94EPS Q/Q22.20%
Dividend-Sales Q/Q11.50%
Insider Own0.80%Inst Own-
Insider Trans14.78%Inst Trans3.61%
Short Float14.47%EarningsOct 30/b
Analyst Recom2.40Target Price43.23
Avg Volume706.55K52W Range27.51 - 39.95
30-Oct-14Reiterated MKM Partners Neutral $31.50 → $33
30-Oct-14 11:28AMAcorda tops 3Q revenue forecasts AP
30-Oct-14 07:10AMACORDA THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E EDGAR Online
30-Oct-14 07:07AMQ3 2014 Acorda Therapeutics Inc Earnings Release - Before Market Open CCBN
30-Oct-14 06:48AMCORRECTING and REPLACING Acorda Therapeutics Reports Third Quarter 2014 Financial Results Business Wire
30-Oct-14 06:19AM6:19 am Acorda Therapeutics beats by $0.39, beats on revs; raises FY14 AMPYRA guidance Briefing.com
28-Oct-14 06:27PMCivitas Buyout Shores Up Acorda's Wall Street Cred at Investor's Business Daily
24-Oct-14 07:22AMACORDA THERAPEUTICS INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Financial Statements EDGAR Online
23-Oct-14 07:00AMAcorda Therapeutics to Host Conference Call to Discuss Third Quarter 2014 Financial Results on October 30, 2014 Business Wire
22-Oct-14 04:11PMAcorda Therapeutics Completes Acquisition of Civitas Therapeutics Business Wire
20-Oct-14 10:00AMInsider Trading Alert - IBKR, C And ACOR Traded By Insiders at TheStreet
Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for multiple sclerosis (MS), spinal cord injury (SCI), and other disorders of the nervous system in the United States. The company's products include Ampyra (dalfampridine), a potassium channel blocker to improve walking in patients with MS; Zanaflex Capsules and Zanaflex tablets, a short-acting drug for the management of spasticity, a symptom of central nervous system disorders; and Qutenza, a dermal patch for the management of neuropathic pain. It is also involved in developing Diazapam Nasal Spray for the treatment of cluster/acute repetitive seizures; Dalfampridine that is in Phase III clinical development program preparations for post-stroke deficits; NP-1998, a topical solution that is in phase III clinical trail for the treatment of neuropathic pain; AC105, which is in Phase II clinical trials for the treatment of SCI; Neuregulin Program that has completed Phase 1 clinical trial for the treatment of heart failure; Remyelinating Antibodies Program, which is in Phase 1 clinical trial for the treatment of MS; and Chondroitinase Program that is in research for the treatment of injuries to the brain and spinal cord, as well as other neurotraumatic indications. The company was founded in 1995 and is headquartered in Ardsley, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Blight AndrewChief Scientifc OfficerOct 20Option Exercise8.1452,338426,031118,125Oct 22 04:03 PM
Blight AndrewChief Scientifc OfficerOct 20Sale32.0852,3381,678,78865,787Oct 22 04:03 PM
Carrazana Enrique J.Chief Medical OfficerOct 15Sale30.893,333102,95835,794Oct 17 04:08 PM
LAWRENCE DAVIDChief of Business OperationsOct 07Sale33.602508,40019,944Oct 09 04:17 PM
ROGERS MICHAEL WChief Financial OfficerOct 07Sale33.105,700188,66041,735Oct 09 04:17 PM
CompanyActua Corporation
IndustryApplication Software
Market Cap756.06MEPS (ttm)-0.79
P/E-EPS this Y-320.70%
Forward P/E-EPS next Y12.50%
PEG-EPS past 5Y-1.30%
P/S10.62EPS next 5Y17.50%
P/B1.58EPS Q/Q-46.20%
Dividend-Sales Q/Q40.70%
Insider Own8.90%Inst Own83.40%
Insider Trans-2.99%Inst Trans0.34%
Short Float5.11%EarningsOct 30/b
Analyst Recom1.70Target Price25.00
Avg Volume153.61K52W Range13.24 - 22.73
29-Oct-14 08:30AMMSDSonline Joins Ranks of 100 Fastest Growing Inner City Companies for Third Straight Year GlobeNewswire
28-Oct-14 05:02AMGovDelivery Presents 'Measure Your Impact' at 5th Annual UK Government Communications Conference Thomson Reuters ONE
28-Oct-14 05:00AMGovDelivery Presents 'Measure Your Impact' at 5th Annual UK Government Communications Conference GlobeNewswire
23-Oct-14 08:30AMActua to Announce Third Quarter 2014 Results Wednesday, November 5th Before Market Opens GlobeNewswire
14-Oct-14 08:30AMNew Cloud-Based Service Provides First Responders With Critical, Lifesaving Information During Chemical Emergencies GlobeNewswire
14-Oct-14 08:00AMGovDelivery Salutes the Federal Government's Best Digital Communicators at 8th Annual Federal Communications Summit GlobeNewswire
01-Oct-14 09:00AMGovDelivery Announces 2014 Outreach & Impact Award Winners GlobeNewswire
26-Sep-14 11:08AMBarrington Research Sees Opportunity To Capitalize On Inefficiencies In Stock For Actua Corp Benzinga
26-Sep-14 08:59AMActua (ACTA) Upgraded From Sell to Hold at TheStreet
23-Sep-14 10:00AMActua Corporation (NASDAQ: ACTA) to Ring The NASDAQ Stock Market Closing Bell GlobeNewswire
Actua Corporation operates as a multi-vertical cloud technology company that creates value for customers and provides transformative efficiency to vertical markets worldwide. It provides Bolt Platform, a cloud-based platform that allows captive and independent insurance agents to meet various commercial and personal property, and casualty insurance needs of their customers; and cloud-based digital communication management platform, which enables government organizations to provide citizens with access to new information, delivering updates through e-mail, mobile text alerts, RSS, and social media channels from government entities at the national, state, and local levels. The company also offers an integrated suite of cloud-based solutions that help companies manage various environmental, health, and safety regulatory compliance requirements worldwide. In addition, it provides a cloud-based publishing platform that allows manufacturers and retailers to share their products in a connected, contextual way among Facebook users; operates a cloud-based healthcare payments network focused exclusively on healthcare providers, payers, and patients; and offers a cloud-based transcript exchange and intelligence platform that enables the exchange of electronic transcripts and other student records among schools, universities, state education agencies, and individuals. The company was formerly known as ICG Group, Inc. and changed its name to Actua Corporation in September 2014. Actua Corporation was founded in 1996 and is headquartered in Radnor, Pennsylvania.
TickerALLE [NASD, S&P 500]
CompanyAllegion plc
IndustryScientific & Technical Instruments
Market Cap4.84BEPS (ttm)0.85
P/E59.16EPS this Y-1.30%
Forward P/E22.64EPS next Y13.26%
PEG-EPS past 5Y-
P/S2.32EPS next 5Y-
P/B3.81EPS Q/Q-235.00%
Dividend-Sales Q/Q6.50%
Insider Own0.20%Inst Own-
Insider Trans97.54%Inst Trans-
Short Float-EarningsOct 30/b
Analyst Recom-Target Price-
Avg Volume729.00K52W Range40.06 - 58.20
30-Oct-14 11:30AMTASER International Weapon Sales Drive Q3 Earnings Beat Zacks
30-Oct-14 07:27AMAllegion posts 3Q profit AP
30-Oct-14 07:07AMQ3 2014 Allegion PLC Earnings Release - Before Market Open CCBN
30-Oct-14 06:53AM6:53 am Allegion beats by $0.04, beats on revs; guides FY14 EPS in-line Briefing.com
30-Oct-14 06:07AMALLEGION PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
30-Oct-14 06:00AMAllegion Reports Third Quarter 2014 Financial Results; Increases Full-Year 2014 EPS Outlook Business Wire
29-Oct-14 12:12PMCORRECTING and REPLACING Allegion to Present at the Robert W. Baird's 2014 Industrial Conference Business Wire
29-Oct-14 09:30AMBocom System Wins a $25 Million Dollar Project in Wuhu City Business Wire
28-Oct-14 05:15PMAllegion to Present at the Robert W. Baird's 2014 Industrial Conference Business Wire
23-Oct-14 03:03AMAssa Abloy profit tops forecast as U.S., Europe demand firms Reuters
Allegion plc is a global provider of security products and solutions. The Company offers a portfolio of mechanical and electronic security products across a range of brands. The Company operates in three geographic regions: Americas; Europe, Middle East, India and Africa (EMEIA), and Asia Pacific. As of November 15, 2013, the Company was selling its security products and solutions under 23 brands in 120 countries, including Schlage, Von Duprin, LCN, CISA and Interflex. It sell a range of security products and solutions for end-users in commercial, institutional and residential facilities worldwide, including into the education, healthcare, government, commercial office and single- and multi-family residential markets. As of November 15, 2013, it operated 18 production facilities, including nine in the Americas region, seven in EMEIA and two in Asia Pacific.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schaffer Dean IDirectorAug 01Buy50.3549624,9731,469Aug 04 05:35 PM
Welch Martin EDirectorAug 01Buy50.3549624,9731,689Aug 04 05:35 PM
HACHIGIAN KIRK SDirectorAug 01Buy50.3549624,9731,689Aug 04 05:34 PM
Cico CarlaDirectorAug 01Buy50.3549624,9731,689Aug 04 05:33 PM
CHESSER MICHAEL JDirectorAug 01Buy50.3549624,9731,689Aug 04 05:32 PM
CompanyAMAG Pharmaceuticals, Inc.
IndustryDiagnostic Substances
Market Cap730.39MEPS (ttm)-0.57
P/E-EPS this Y43.60%
Forward P/E6.74EPS next Y923.30%
PEG-EPS past 5Y36.40%
P/S8.21EPS next 5Y-
P/B3.78EPS Q/Q22.20%
Dividend-Sales Q/Q26.50%
Insider Own2.70%Inst Own-
Insider Trans48.63%Inst Trans1.15%
Short Float23.66%EarningsOct 30/b
Analyst Recom1.00Target Price39.00
Avg Volume484.88K52W Range16.49 - 34.59
30-Oct-14 08:00AMAMAG Pharmaceuticals Inc Earnings Call scheduled for 8:00 am ET today CCBN
30-Oct-14 07:15AM7:15 am AMAG Pharma beats by $0.12, reports revs in-line Briefing.com
30-Oct-14 07:07AMQ3 2014 AMAG Pharmaceuticals Inc Earnings Release - Before Market Open CCBN
30-Oct-14 07:01AMAMAG PHARMACEUTICALS INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online
30-Oct-14 07:00AMAMAG Pharmaceuticals Reports Financial Results for Third Quarter and Nine Months Ended September 30, 2014 GlobeNewswire
29-Oct-14 04:20PMWill Teva (TEVA) Beat Q3 Earnings on Strong Generic Sales? Zacks
29-Oct-14 02:28PMWill AbbVie (ABBV) Disappoint in this Earnings Season? Zacks
29-Oct-14 01:18PMAMAG Pharmaceuticals, Inc. -- Moody's assigns B2 CFR to AMAG Pharmaceuticals; stable outlook at Moody's
28-Oct-14 05:01PMWill Cigna's (CI) Business Diversity Drive Q3 Earnings Beat? Zacks
28-Oct-14 02:10PMSarepta Slumps as Eteplirsen NDA Submission Gets Delayed Zacks
AMAG Pharmaceuticals, Inc. develops and commercializes specialty pharmaceutical products. The company markets Feraheme (ferumoxytol) injection for use as an intravenous (IV) iron replacement therapy for the treatment of iron deficiency anemia in adult patients with chronic kidney disease; and MuGard Mucoadhesive Oral Wound Rinse for the management of oral mucocitis/stomatiits and various types of oral wounds. It markets Feraheme in the United States and Canada; and as Rienso in the European Union. The company sells Feraheme to authorized wholesalers and specialty distributors. AMAG Pharmaceuticals, Inc. has a license, development, and commercialization agreement with Takeda Pharmaceutical Company Limited to develop and commercialize Feraheme/Rienso as a therapeutic agent in Europe, certain Asia-Pacific countries, the Commonwealth of Independent States, Canada, India, and Turkey; and collaboration and exclusive license agreement with 3SBio for the development and commercialization of Feraheme as an IV iron replacement therapeutic agent in China. The company was founded in 1981 and is based in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
White Christopher GChief Business OfficerFeb 26Sale21.584008,63224,000Feb 26 05:11 PM
White Christopher GChief Business OfficerFeb 25Sale21.714349,42224,400Feb 26 05:11 PM
White Christopher GChief Business OfficerJan 09Sale20.832,00041,65924,834Jan 09 07:13 PM
White Christopher GChief Business OfficerJan 08Sale23.912,00047,82026,834Jan 09 07:13 PM
White Christopher GChief Business OfficerJan 07Sale24.102,50060,25028,834Jan 07 04:54 PM
TickerAMT [NYSE, S&P 500]
CompanyAmerican Tower Corporation
IndustryREIT - Diversified
Market Cap37.65BEPS (ttm)1.79
P/E53.10EPS this Y-13.80%
Forward P/E33.15EPS next Y27.48%
PEG2.62EPS past 5Y18.90%
P/S10.00EPS next 5Y20.28%
P/B8.54EPS Q/Q132.00%
Dividend1.51%Sales Q/Q27.50%
Insider Own0.11%Inst Own96.00%
Insider Trans-4.39%Inst Trans0.04%
Short Float1.20%EarningsOct 30/b
Analyst Recom1.70Target Price107.89
Avg Volume1.99M52W Range74.78 - 99.53
30-Oct-14 01:45PMAmerican Tower Lags Q3 Earnings, Beats on Revenues Zacks
30-Oct-14 01:09PMAmerican Tower (AMT) Earnings Report: Q3 2014 Conference Call Transcript at TheStreet
30-Oct-14 11:08AMAmerican Tower Corp Beats Q3 Estimates, Shares Surge 3% Benzinga
30-Oct-14 10:19AMAmerican Tower (AMT) Is Today's Momo Momentum Stock at TheStreet
30-Oct-14 08:30AMAmerican Tower Corp Earnings Call scheduled for 8:30 am ET today CCBN
30-Oct-14 07:33AMAmerican Tower misses 3Q profit forecasts AP
30-Oct-14 07:11AMAMERICAN TOWER CORP /MA/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online
30-Oct-14 07:07AMQ3 2014 American Tower Corp Earnings Release - 07:00 am ET CCBN
30-Oct-14 07:00AMAmerican Tower Corporation Reports Third Quarter 2014 Financial Results Business Wire
28-Oct-14 06:16PMMobile Growth Spurs Demand For Cell Tower Real Estate at Investor's Business Daily
American Tower Corporation is a real estate investment trust. It invests in the real estate markets across the globe. The firm through its subsidiaries owns, operates and develops wireless and broadcast communications real estate. Through its subsidiaries it leases antenna space on multi-tenant communications sites to wireless service providers, radio and television broadcast companies, wireless data providers, government agencies and municipalities and tenants in a number of other industries. American Tower Corporation was founded in 1995 and is headquartered in Boston, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
TAICLET JAMES D JRChairman, President and CEOOct 13Option Exercise37.5240,0001,500,80076,497Oct 15 05:15 PM
KATZ CAROLYNDirectorOct 13Sale93.985,000469,8889,177Oct 15 05:12 PM
TAICLET JAMES D JRChairman, President and CEOOct 13Sale93.9940,0003,759,63536,497Oct 15 05:15 PM
Bartlett Thomas AEVP & Chief Financial OfficerOct 08Option Exercise76.9019,4311,494,24452,536Oct 10 04:22 PM
Bartlett Thomas AEVP & Chief Financial OfficerOct 08Sale95.0019,4311,845,94533,105Oct 10 04:22 PM
TickerANR [NYSE]
CompanyAlpha Natural Resources, Inc.
IndustryIndustrial Metals & Minerals
Market Cap473.88MEPS (ttm)-6.26
P/E-EPS this Y54.40%
Forward P/E-EPS next Y8.10%
PEG-EPS past 5Y-30.50%
P/S0.11EPS next 5Y5.00%
P/B0.13EPS Q/Q-176.20%
Dividend-Sales Q/Q-21.00%
Insider Own0.80%Inst Own75.10%
Insider Trans11.38%Inst Trans-1.05%
Short Float25.76%EarningsOct 30/b
Analyst Recom3.10Target Price3.81
Avg Volume11.31M52W Range1.59 - 8.30
30-Oct-14 12:58PMAlpha Natural Resources 3Q results top Street AP
30-Oct-14 12:31PMAlpha Natural Resources (ANR) Stock Drops as More Coal Production Cuts Loom at TheStreet
30-Oct-14 12:13PMSTORY REMOVED:BC-US--Earns-Alpha Natural Resources AP
30-Oct-14 11:15AMAlpha Natural Resources Posts Narrower-than-Expected Q3 Loss Zacks
30-Oct-14 08:25AMAlpha Says Coal Industry Will Probably Make More Cuts at Bloomberg
30-Oct-14 08:18AMCoal miner Alpha Natural posts smaller loss Reuters
30-Oct-14 08:10AM8:10 am Alpha Natural Resources beats by $0.17, beats on revs; Increasing 2014 Shipment Guidance Briefing.com
30-Oct-14 08:09AMALPHA NATURAL RESOURCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online
30-Oct-14 08:05AMAlpha Natural Resources Announces Results for Third Quarter 2014 PR Newswire
30-Oct-14 07:48AMAlpha Natural Resources posts 3Q loss AP
Alpha Natural Resources, Inc., together with its subsidiaries, is engaged in extracting, processing, and marketing thermal and metallurgical coal in Virginia, West Virginia, Kentucky, Pennsylvania, and Wyoming. As of December 31, 2013, the company operated 81 mines and 25 coal preparation plants in Northern and Central Appalachia and the Powder River Basin with approximately 4.3 billion tons of proven and probable coal reserves. The company also repairs and resells equipment and parts used in surface mining and supporting preparation plant operations; manufactures patented particulate scrubbers and filters for underground diesel engine applications; and rebuilds underground mining equipment. In addition, it owns and operates third-party end-user coal handling facilities; purchases and sells third party coal; sells non-strategic assets, such as timber, gas, and oil rights; leases and sells non-strategic surface properties and reserves; and provides coal and environmental analysis services. The company serves electric utilities, steel and coke producers, industrial customers, and energy traders and brokers. Alpha Natural Resources, Inc. was founded in 2002 and is based in Bristol, Virginia.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Alpha Natural Resources, Inc.DirectorAug 19Sale26.283,114,82581,846,0766,408,985Aug 21 04:47 PM
TickerAPD [NYSE, S&P 500]
CompanyAir Products & Chemicals Inc.
IndustryChemicals - Major Diversified
Market Cap27.45BEPS (ttm)4.82
P/E26.73EPS this Y1.70%
Forward P/E20.23EPS next Y11.07%
PEG2.74EPS past 5Y-1.00%
P/S2.65EPS next 5Y9.77%
P/B3.56EPS Q/Q7.40%
Dividend2.39%Sales Q/Q3.40%
Insider Own0.10%Inst Own87.50%
Insider Trans40.13%Inst Trans-0.12%
Short Float1.07%EarningsOct 30/b
Analyst Recom2.60Target Price135.69
Avg Volume1.83M52W Range100.87 - 136.66
30-Oct-14 07:42AMAIR PRODUCTS & CHEMICALS INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statem EDGAR Online
30-Oct-14 07:13AM[$$] Air Products Sees Growth in Segments, Pushes Cost Cutting at The Wall Street Journal
30-Oct-14 07:07AMQ4 2014 Air Products Earnings Release - Before Market Open CCBN
30-Oct-14 06:08AM6:08 am Air Products beats by $0.04, misses on revs; guides Q1 EPS in-line; guides FY15 EPS in-line Briefing.com
30-Oct-14 06:00AMAir Products Reports Quarterly EPS of $1.66* PR Newswire
29-Oct-14 10:00AMAir Products to Highlight Industrial Gas Supply and Process Optimization Solutions for Oil Recyclers at NORA PR Newswire
27-Oct-14 02:30PMAir Products' High Efficiency Supply System Reduces Oxygen Loss At Hyperbaric Oxygen Therapy Treatment Center PR Newswire
27-Oct-14 10:30AMAir Products to Work with Technip on Inner Mongolia LNG Project PR Newswire
22-Oct-14 10:41AMNew Air Products Lab Will Help Oil Recyclers Optimize Hydrotreatment Processes PR Newswire
20-Oct-14 06:25PMAir Products (APD) Hikes Electronics Product Prices Zacks
Air Products and Chemicals, Inc. provides atmospheric gases, process and specialty gases, performance materials, equipment, and services worldwide. The company operates through four segments: Merchant Gases, Tonnage Gases, Electronics and Performance Materials, and Equipment and Energy. The Merchant Gases segment sells atmospheric gases, such as oxygen, nitrogen, and argon; process gases comprising hydrogen and helium and carbon dioxide; and medical and specialty gases for the metal, glass, chemical processing, food processing, healthcare, steel, general manufacturing, and petroleum and natural gas industries. The Tonnage Gases segment offers hydrogen, carbon monoxide, nitrogen, oxygen, and syngas to the energy production and refining, chemical, and metallurgical industries. The Electronics and Performance Materials segment provides nitrogen trifluoride, silane, arsine, phosphine, white ammonia, silicon tetrafluoride, carbon tetrafluoride, hexafluoromethane, critical etch gases, and tungsten hexafluoride; and tonnage gases, chemicals mechanical planarization slurries, specialty chemicals, and services and equipment for the manufacture of silicon and compound semiconductors, and thin film transistor liquid crystal displays. This segment also offers performance materials for a range of products, including coatings, inks, adhesives, civil engineering, personal care, institutional and industrial cleaning, mining, oil refining, and polyurethanes. The Equipment and Energy segment designs and manufactures cryogenic equipment for air separation, hydrocarbon recovery and purification, natural gas liquefaction, and helium distribution; and provides plant design, engineering, procurement, and construction management services for the chemical and petrochemical manufacturing, oil and gas recovery and processing, and steel and primary metals processing industries. Air Products and Chemicals, Inc. was founded in 1940 and is headquartered in Allentown, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Crocco Michael SV.P. and ControllerOct 01Option Exercise54.175,400292,51821,184Oct 02 10:15 AM
Ghasemi SeifiChairman, Pres. and CEOAug 01Buy132.8425,0003,320,96877,026Aug 01 04:23 PM
Stanley John D.SR VP and General CounselJul 25Sale135.8755275,00058Jul 28 02:24 PM
Stanley John D.SR VP and General CounselJul 24Option Exercise67.118,400563,74229,864Jul 28 02:24 PM
Mattimore Patricia ASenior Vice PresidentJul 24Option Exercise59.1410,000591,38017,205Jul 28 02:24 PM
1 2 3 4 5 6 ... 10 ... 17 next